Hypoalbuminemia and cisplatin-induced acute kidney injury

Hypoalbuminemia and cisplatin-induced acute kidney injury

BackgroundCisplatin binds to serum albumin in the body at a rate of 90%, and high levels of free cisplatin are a significant cause of its nephrotoxicity. Therefore, hypoalbuminemia theoretically poses a significant risk factor for cisplatin-induced acute kidney injury (CIA) and can be easily correct...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wen-Jun Yin, Yu-Jie Huang, Qing Zhu, Xiao-Qing Lin, Hui-Ling Piao, Qian-Qian Yu, Chang-Hong Lai, Guang-Liang Zhou, Ling-Yun Zhou, Kun Liu, Xiao-Cong Zuo, Shan-Ru Zuo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Pharmacology
Subjects:	cisplatin acute kidney injury hypoalbuminemia meta-analysis retrospective study
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1510477/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients
by: Ekaterina Fedorova, et al.
Published: (2025-01-01)

Construction of geriatric hypoalbuminemia predicting model for hypoalbuminemia patients with and without pneumonia and explainability analysis
by: Ziqi Liu, et al.
Published: (2024-12-01)

Impact of Hypoalbuminemia on Outcomes Following Hepatic Resection: A NSQIP Retrospective Cohort Analysis of 26,394 Patients
by: Dunavan Morris-Janzen, et al.
Published: (2024-10-01)

Hypoalbuminemia on admission in diabetic patients correlates with severity of illness in COVID-19: A retrospective clinical study and literature review
by: Mayumi Shoji, et al.
Published: (2024-09-01)

Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy
by: Chih-Chung Cheng, et al.
Published: (2024-12-01)

Mitochondrial Dysfunction‐Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin‐Induced Acute Kidney Injury
by: Nan‐Nan Liang, et al.
Published: (2024-11-01)

Prediction of Cisplatin‐Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record Information
by: Kaori Ambe, et al.
Published: (2025-01-01)

Mechanism of dexmedetomidine protection against cisplatin induced acute kidney injury in rats
by: Zeng-lu Zheng, et al.
Published: (2024-12-01)

Switchable ROS generator and scavenger to prevent the cisplatin induced acute kidney injury and improve efficacy via synergistic chemodynamic/immune therapy
by: Yanan Ren, et al.
Published: (2024-12-01)

Protective effect of Panax ginseng extract on cisplatin-induced AKI via downregulating cell death associated genes
by: Reza Alipanah-Moghadam, et al.
Published: (2025-01-01)

Sodium Phenylbutyrate Attenuates Cisplatin-Induced Acute Kidney Injury Through Inhibition of Pyruvate Dehydrogenase Kinase 4
by: Chang Joo Oh, et al.
Published: (2024-12-01)

Association between serum albumin levels at admission and clinical outcomes in pediatric intensive care units: a multi-center study
by: Hatice Feray Ari, et al.
Published: (2024-12-01)

Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01)

Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01)

Diet Supplementation with Ketoanalogues, Inulin, and Calcium Citrate in Chronic Kidney Disease: A Retrospective Cohort
by: Martín Calderón-Juárez, et al.
Published: (2024-12-01)

Application of cisplatin and other platinum-containing drugs in cancer therapy: Comprehensive review
by: A.S Arul Prishya, et al.
Published: (2024-01-01)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
by: Lili Zhao, et al.
Published: (2019-05-01)

Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
by: Hanan Seddiek, et al.
Published: (2025-02-01)

Ellagic acid ameliorates cisplatin-induced acute kidney injury by regulating inflammation and SIRT6/TNF-α signaling
by: Yuqi Gao, et al.
Published: (2023-11-01)

RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells
by: Hangyu Xu, et al.
Published: (2025-01-01)

Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy—A State-of-the-Art Review
by: Olaf Rose, et al.
Published: (2024-12-01)

Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells
by: Amirhosein Maharati, et al.
Published: (2025-01-01)

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells
by: Wanhong He, et al.
Published: (2024-12-01)

Quantification of Metabolic Acidosis at Bedside by S.A.L.T Approach
by: Harshitha Seshadri, et al.
Published: (2024-12-01)

Release of cisplatin from bioinert templates in mixture with hydroxyapatite
by: V.K. Krut’ko, et al.
Published: (2024-12-01)

PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway
by: Yifan Wu, et al.
Published: (2025-01-01)

Insight into the current practice of ototoxicity monitoring during cisplatin therapy
by: N. M. Santucci, et al.
Published: (2021-03-01)

Magnesium Imbalance before and during Concomitant Chemoradiation in Cervical Cancer Patients: A Prospective Interventional Study
by: Monica Verma, et al.
Published: (2024-12-01)

Cisplatin-Induced Renal Failure Measured by Glomerular Filtration Rate (GFR) with <sup>99</sup>mTc-DTPA Scans in Cancer Patients: A Systematic Review and Meta-Analysis
by: Mansour M. Alqahtani
Published: (2024-11-01)

Tumor-associated macrophage-derived exosome miR-194 confers cisplatin resistance in GC cells
by: Yi Zhou, et al.
Published: (2025-02-01)

Curcumin mediates glutathione depletion via metal–organic framework nanocarriers to enhance cisplatin chemosensitivity on esophageal cancer
by: Yunhao Sun, et al.
Published: (2024-12-01)

Cisplatin and dexamethasone separate and combined effect on nephrotoxic processes in female rats
by: Zhenya Yavroyan, et al.
Published: (2024-11-01)

β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis
by: Ruixue Tian, et al.
Published: (2024-12-01)

Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers
by: Mai G. Awad, et al.
Published: (2024-11-01)

Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis
by: Xinyan Hao, et al.
Published: (2025-01-01)

Effects of Repeated Cisplatin and Monosodium Glutamate on Visceral Sensitivity in Rats
by: Yolanda López-Tofiño, et al.
Published: (2024-12-01)

Cisplatin and lipopolysaccharide co-administration for renal injury model in mice
by: Sae-Byeok Hwang, et al.
Published: (2024-12-01)

Loss of Fascin2 increases susceptibility to cisplatin-induced hearing impairment and cochlear cell apoptosis in mice
by: Yan Wang, et al.
Published: (2024-07-01)

Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer
by: Takahiro Kimura, et al.
Published: (2018-02-01)

Predictive factors of progression to chronic glomerulonephritis in pediatric patients with post streptococcal acute glomerulonephritis
by: Ida Ayu Laksmi Arnita Utari, et al.
Published: (2024-11-01)